Market Intelligence, ORTEX

ORTEX Market Intel

Market Intelligence

Global Financial Data and Analytics Platform

ORTEX

ORTEX is a global financial data and analytics platform providing real-time securities lending and short interest data, index rebalance data, holdings and insider transactions, trading signals, corporate actions and news,  stock machine learning and factor scores and other analytics. The majority of the data are downloadable and accessible through APIs.

Equity Derivatives

<ul><li>Sentiment read - Options activity split sharply this week.</li><li>Earnings-driven put buying dominated in EDA software, construction, and biotech.</li><li>On the other side, banks and energy names saw aggressive call buying - several hitting 52-week PCR lows before results.</li></ul>

Sentiment read - Options activity split sharply this week.Earnings-driven put buying dominated in EDA software, construction, and biotech.On the other side, banks and energy names saw aggressive call buying - several hitting 52-week PCR lows before results.

Options Weekly: Earnings Fear and Bullish Bets Dominate Options Week

United States

Immix Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel class of tissue-specific therapeutics in oncology and inflammation to treat inflammatory bowel disease, including ulcerative colitis and crohn's diseases. Immix Biopharma serves customers in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Immix Biopharma Inc (IMMX US)

Options Weekly: Earnings Fear and Bullish Bets Dominate Options Week

Sentiment read - Options activity split sharply this week. Earnings-driven put buying dominated in EDA software, construction, and biotech. On the...

ORTEX Market Intel

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)